Cardiomyocyte proliferation: A platform for mammalian cardiac repair

56Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Permanent loss of heart muscle cells, cardiomyocytes, is a major mechanism resulting in ventricular dysfunction and heart failure. Potential solutions to this problem could be either to stimulate the heart to generate new cells by inducing existing cardiomyocytes to divide or to activate or deliver stem cells/ progenitor cells to multiply and subsequently differentiate into cardiomyocytes. Utilizing in vitro and in vivo approaches, p38 MAP kinase has recently been identified as a key negative regulator of cardiomyocyte proliferation. This work provides strong evidence that adult mammalian cardiomyocytes can divide. This review discusses the potential of the induction of mammalian cardiomyocyte proliferation as a therapeutic strategy for myocardial repair. ©2005 Landes Bioscience.

Cite

CITATION STYLE

APA

Engel, F. B. (2005). Cardiomyocyte proliferation: A platform for mammalian cardiac repair. Cell Cycle. Taylor and Francis Inc. https://doi.org/10.4161/cc.4.10.2081

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free